Advertisement

Topics

Two studies support intensive blood pressure control for long-term health, quality of life

13:10 EDT 23 Aug 2017 | Medical Xpress

Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg - far below the standard guidelines of 140 mmHg - to reduce the risk of heart disease in high-risk patients with hypertension. The new research shows that intensive blood pressure control is well-tolerated by patients and is cost-effective in terms of health-related quality of life and financial costs to the healthcare system.

Original Article: Two studies support intensive blood pressure control for long-term health, quality of life

NEXT ARTICLE

More From BioPortfolio on "Two studies support intensive blood pressure control for long-term health, quality of life"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...